Global Anti-inflammatory Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Anti-inflammatory Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

According to our (Global Info Research) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 121270 million in 2023 and is forecast to a readjusted size of USD 181020 million by 2030 with a CAGR of 6.0% during review period.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

This report is a detailed and comprehensive analysis for global Anti-inflammatory Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Anti-inflammatory Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030

Global Anti-inflammatory Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Anti-inflammatory Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Anti-inflammatory Therapeutics market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Anti-inflammatory Therapeutics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Anti-inflammatory Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Market segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

Market segment by players, this report covers
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin, and global market share of Anti-inflammatory Therapeutics from 2019 to 2024.

Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-inflammatory Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Therapeutics.

Chapter 13, to describe Anti-inflammatory Therapeutics research findings and conclusion.